Mod GRF, GHRP-2 10mg (Blend)

Peptide Science research editorial team.

Mod GRF plus GHRP-2 10mg Blend Overview

Mod GRF plus GHRP-2 10mg Blend from Peptide Science is the dual-active lyophilised vial pairing the modified GHRH analogue Mod GRF 1-29 (CJC-1295 without the Drug Affinity Complex) with the 6-amino-acid ghrelin-receptor agonist GHRP-2 in a single reconstitution event. The Mod GRF naming convention is used interchangeably with CJC-1295 No DAC in published research literature.

Combined Pathway Background

Mod GRF 1-29 binds the GHRH receptor on pituitary somatotrophs and raises intracellular cyclic AMP via adenylate cyclase activation. GHRP-2 binds the separate GHS-R1a ghrelin receptor and acts through a phospholipase-C-coupled pathway. The two receptors converge on the same downstream growth-hormone-release step, which is the structural basis for paired administration in additive-secretagogue cell-culture research. Browse the broader growth-hormone peptide range.

Vial Specifications

Reconstitution and Handling

The dual-active vial reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. For the equivalent CJC-1295-naming variant of the same pairing, see CJC-1295 No DAC plus GHRP-2 10mg Blend.

Quality and Shipping

Each batch passes HPLC at greater than 99 percent for each active, with mass-spectrometry confirmation. A Certificate of Analysis accompanies every order listing each active and its measured purity. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging.

For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws.